Are burr cells present in patients with Sjögren's (Sjögren's syndrome)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Burr Cells in Sjögren's Syndrome

Based on the available evidence, there is no indication that burr cells are present in patients with Sjögren's syndrome. The clinical manifestations and hematological findings in Sjögren's syndrome do not include burr cells as a characteristic feature.

Clinical Manifestations of Sjögren's Syndrome

Sjögren's syndrome is a chronic autoimmune disorder characterized by:

  • Decreased lacrimal and salivary gland secretion (sicca complex) 1
  • Keratoconjunctivitis sicca and xerostomia (dry eyes and mouth) 2
  • Lymphocytic infiltration of exocrine glands 3

Key Clinical Features:

  • Ocular symptoms: dry eyes, irritation, foreign body sensation, light sensitivity 1
  • Oral symptoms: dry mouth, need for liquids to swallow dry foods, frequent dental cavities 1
  • Systemic manifestations: fatigue, arthralgia, myalgia 1
  • Pulmonary complications: found in approximately 10% of patients, including interstitial pneumonitis, xerotrachea, and bronchiectasis 2
  • Cough: observed in >50% of patients with Sjögren's syndrome 2

Hematological and Laboratory Findings in Sjögren's Syndrome

The diagnostic workup for Sjögren's syndrome focuses on:

  1. Serological markers:

    • Anti-SSA/Ro antibodies
    • Anti-SSB/La antibodies
    • Antinuclear antibody (ANA)
    • Rheumatoid factor (RF) 1
  2. Histopathological findings:

    • Focal lymphocytic sialadenitis on lip biopsy 2, 1
    • Presence of germinal centers in some cases 2
  3. Other laboratory abnormalities:

    • B-cell hyperactivity resulting in autoantibody production 4
    • Immune complex deposition 4
    • In some cases, cytopenias (leukopenia, thrombocytopenia) 5

Renal and Vascular Manifestations

While Sjögren's syndrome can involve multiple organ systems, the renal manifestations typically include:

  • Interstitial nephritis with mild proteinuria and tubular dysfunction (most common) 4
  • Rarely, glomerular involvement due to immune complex deposition 4
  • In rare cases, IgA nephropathy 6

Vascular manifestations may include:

  • Leukocytoclastic vasculitis 6
  • Raynaud's phenomenon 1

Important Diagnostic Considerations

The diagnosis of Sjögren's syndrome requires:

  • Total score of ≥4 based on the weighted sum of anti-SSA/Ro antibody positivity, focal lymphocytic sialadenitis, abnormal ocular staining score, Schirmer's test result, and unstimulated salivary flow rate 1
  • Salivary gland assessment and biopsy 1
  • Tear film assessment 1

Clinical Implications

The absence of burr cells in Sjögren's syndrome is significant because:

  • Burr cells (echinocytes) are typically associated with uremia, liver disease, or other specific conditions
  • Hematological abnormalities in Sjögren's syndrome are more commonly related to autoimmune processes rather than red blood cell morphology changes
  • When evaluating a patient with Sjögren's syndrome who presents with anemia or other hematological abnormalities, clinicians should focus on more typical manifestations such as cytopenias related to autoimmunity rather than looking for burr cells

Monitoring and Management

For patients with Sjögren's syndrome:

  • Regular monitoring for development of lymphoma is essential, particularly in patients with decreased C4 levels 1
  • Co-management with a rheumatologist is recommended due to potential systemic complications 1
  • Baseline pulmonary function tests should be performed in all patients 1

In conclusion, while Sjögren's syndrome has numerous clinical manifestations affecting multiple organ systems, burr cells are not a recognized hematological feature of this condition based on the current medical literature.

References

Guideline

Sjögren's Syndrome Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Current Aspects of Pathogenesis in Sjögren's Syndrome.

Therapeutic advances in musculoskeletal disease, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.